Clinical trial
Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer
NCT00099879 · Bristol-Myers Squibb, Industry · Terminated
Key facts
| NCT number | NCT00099879 |
|---|---|
| Title | Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer |
| Official title | A Randomized, Two-Cohort Phase II Study of Two Doses of BMS-275183 Given on a Weekly Schedule in Patients With Pre-Treated Non-Small Cell Lung Cancer |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | BMS-275183 |
| Primary completion | Mar 1, 2006 |
| First posted | Dec 22, 2004 |
| Last update posted | Mar 2, 2010 |
| Countries | Belgium, France, Italy, Netherlands, Spain, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: